Christopher P. Kiritsy - 02 Dec 2024 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Role
Director
Signature
/s/ Thomas Bures, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
02 Dec 2024
Net transactions value
$0
Form type
4
Filing time
09 Dec 2024, 07:32:58 UTC
Previous filing
23 Jun 2023
Next filing
17 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (right to buy) Award $0 +500 $0.000000 500 02 Dec 2024 Common Stock 500 $16.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to 100% of the underlying shares on December 2, 2025, subject to the Reporting Person's continued service as a director through the vesting date.